VIS Stock Analysis: Viscofan | MC
Packaging & Containers | MC, Spain | Market Cap: 2.624m EUR | 12M Return: -2.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.25M
EPS Trend: -9.5%
Rev. Trend: 9.6%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Viscofan, S.A. is a Spanish manufacturer and global distributor of casings used primarily by the food processing industry. Founded in 1975 and headquartered in Tajonar, Spain, the company sells its products across Europe, the Middle East, Africa, Asia-Pacific, North America, and South America. Its product range spans cellulose, collagen, fibrous, plastics, and functional casings, as well as specialized solutions for plant-based foods, construction materials, nutraceuticals, and medical applications. Notable branded offerings include the Total Control Net collagen film cover for meat products and the TITANIUM LINE of fibrous casings.
Listed on the Spanish exchange under the ticker VIS and classified within the Consumer Staples sector (Packaged Foods & Meats), Viscofan operates a business-to-business model that supplies casing inputs to meat processors and other food manufacturers worldwide, making it a key supplier in the global processed meats value chain.
- Collagen and cellulose casings pricing offsets raw material inflation
- European energy costs pressure casings manufacturing margins
- Veggie and nutra-pharma segments drive higher-margin growth
| Net Income: 162.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -3.98 > 1.0 |
| NWC/Revenue: 33.39% < 20% (prev 34.32%; Δ -0.93% < -1%) |
| CFO/TA 0.12 > 3% & CFO 188.4m > Net Income 162.2m |
| Net Debt (263.8m) to EBITDA (272.0m): 0.97 < 3 |
| Current Ratio: 1.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.0m) vs 12m ago 1.13% < -2% |
| Gross Margin: 44.68% > 18% (prev 68.02%; Δ -23.33% > 0.5%) |
| Asset Turnover: 84.32% > 50% (prev 84.35%; Δ -0.04% > 0%) |
| Interest Coverage Ratio: 18.56 > 6 (EBIT TTM 187.5m / Interest Expense TTM 10.1m) |
| A: 0.28 (Total Current Assets 854.6m - Total Current Liabilities 437.5m) / Total Assets 1.52b |
| B: 0.02 (Retained Earnings 33.7m / Total Assets 1.52b) |
| C: 0.13 (EBIT TTM 187.5m / Avg Total Assets 1.48b) |
| D: 1.61 (Book Value of Equity 932.0m / Total Liabilities 578.4m) |
| Altman-Z'' = 4.42 = AA |
| DSRI: 1.05 (Receivables 346.3m/323.4m, Revenue 1.25b/1.22b) |
| GMI: 1.52 (GM 68.02% / 44.68%) |
| AQI: 1.25 (AQ_t 0.07 / AQ_t-1 0.06) |
| SGI: 1.02 (Revenue 1.25b / 1.22b) |
| TATA: -0.02 (NI 162.2m - CFO 188.4m) / TA 1.52b) |
| Beneish M = -2.35 (Cap -4..+1) = BBB |
As of July 11, 2026, the stock is trading at EUR 55.10 with a total of 206,183 shares traded. Over the past week, the price has changed by -6.13%, over one month by -6.77%, over three months by -8.99% and over the past year by -2.81%.
Current recommended Stop Loss: 54.00 (which is 2% or 1.3 ATR below the current price).
Viscofan has no consensus analysts rating.
P/E Trailing = 16.1972
P/E Forward = 17.7305
P/S = 2.0997
P/B = 2.874
P/EG = 2.1567
Revenue TTM = 1.25b EUR
EBIT TTM = 187.5m EUR
EBITDA TTM = 272.0m EUR
Long Term Debt = 67.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 264.5m EUR (from shortTermDebt, last quarter)
Debt = 344.5m EUR (from shortLongTermDebtTotal, last quarter) + Leases 12.2m
Net Debt = 263.8m EUR (calculated: Debt 344.5m - CCE 80.7m)
Enterprise Value = 2.89b EUR (2.62b + Debt 344.5m - CCE 80.7m)
Interest Coverage Ratio = 18.56 (Ebit TTM 187.5m / Interest Expense TTM 10.1m)
EV/FCF = 26.74x (Enterprise Value 2.89b / FCF TTM 108.0m)
FCF Yield = 3.74% (FCF TTM 108.0m / Enterprise Value 2.89b)
FCF Margin = 8.64% (FCF TTM 108.0m / Revenue TTM 1.25b)
Net Margin = 12.98% (Net Income TTM 162.2m / Revenue TTM 1.25b)
Gross Margin = 44.68% ((Revenue TTM 1.25b - Cost of Revenue TTM 691.2m) / Revenue TTM)
Gross Margin QoQ = 36.84% (prev 35.71%)
Tobins Q-Ratio = 1.91 (Enterprise Value 2.89b / Total Assets 1.52b)
Interest Expense / Debt = 2.93% (Interest Expense 10.1m / Debt 344.5m)
Taxrate = 9.77% (17.3m / 177.4m)
NOPAT = 169.2m (EBIT 187.5m * (1 - 9.77%))
Current Ratio = 1.95 (Total Current Assets 854.6m / Total Current Liabilities 437.5m)
Debt / Equity = 0.37 (Debt 344.5m / totalStockholderEquity, last quarter 932.0m)
Debt / EBITDA = 0.97 (Net Debt 263.8m / EBITDA 272.0m)
Debt / FCF = 2.44 (Net Debt 263.8m / FCF TTM 108.0m)
Total Stockholder Equity = 928.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.95% (Net Income 162.2m / Total Assets 1.52b)
RoE = 17.48% (Net Income TTM 162.2m / Total Stockholder Equity 928.2m)
RoCE = 18.83% (EBIT 187.5m / Capital Employed (Equity 928.2m + L.T.Debt 67.8m))
RoIC = 13.22% (NOPAT 169.2m / Invested Capital 1.28b)
WACC = 5.14% (E(2.62b)/V(2.97b) * Re(5.47%) + D(344.5m)/V(2.97b) * Rd(2.93%) * (1-Tc(0.10)))
Discount Rate = 5.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 15.56 | Cagr: -0.09%
[DCF] Terminal Value 73.10% ; FCFF base≈129.1m ; Y1≈113.2m ; Y5≈91.5m
[DCF] Fair Price = 26.40 (EV 1.47b - Net Debt 263.8m = Equity 1.20b / Shares 45.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -9.49 | EPS CAGR: -0.91% | SUE: N/A | # QB: 0
Revenue Correlation: 9.62 | Revenue CAGR: 0.21% | SUE: -3.32 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=3.54 | Chg30d=-1.60% | Revisions=-25% | GrowthEPS=+0.5% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=3.90 | Chg30d=-0.76% | Revisions=-40% | GrowthEPS=+10.3% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: -50% (up=0, down=3)